FDA OKs anti-itch treatment Hydrocortisone-D from Apricus

08/23/2011 | San Diego Union-Tribune

Apricus Biosciences' Hydrocortisone-D, an anti-itch medicine, was approved by the FDA. The reformulated over-the-counter drug features Apricus' NexACT molecules, boosting drug absorption through the skin. Last week, the drugmaker gained regulatory approval for anti-fungal treatment Tolnaftate-D.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ